Medicine News and Research

RSS

Mount Sinai School of Medicine ranked 18th among America's medical schools

The 2011 US News & World Report has ranked Mount Sinai School of Medicine 18th out of 146 medical schools and schools of osteopathic medicine nationwide, jumping from 32nd in 2005. Mount Sinai's improvement in the rankings is one of the largest by any institution.

20 Apr 2010

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its primary endpoint>Europe, is due to report in the third quarter of 2010.

20 Apr 2010

Thousands of premature babies could benefit from probiotics

Thousands more very premature babies could survive each year if probiotics were added to their feeds, according to research published today in Pediatrics, a leading clinical journal.

20 Apr 2010

UAB researchers discover four miRNAs to assess survival rate of colorectal cancer patients

Researchers at the University of Alabama at Birmingham Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

20 Apr 2010

Homeopathy – Is it a safer and effective alternative?

Studies have shown that nearly 45% Britons rely on Homeopathy, a branch of medicine that has been doubted by many and loved by an equal number.

20 Apr 2010

Viral Genetics relocates research facilities to Georgetown

Biotech company Viral Genetics, Inc.,, is relocating its research facilities to the life science cluster in Georgetown, Texas. Lead scientist Dr. Karen Newell has joined the faculty of Texas A&M University's College of Medicine and has received a $750,000 grant to research bio-fuels from the Texas Emerging Technology Fund.

20 Apr 2010

Atherotech to showcase VAP Cholesterol Test at Internal Medicine 2010

Atherotech Inc. announced it will exhibit its VAP® Cholesterol Test in booth #1305 at Internal Medicine 2010, the annual scientific meeting of the American College of Physicians (ACP). The meeting takes place April 22-24, 2010, at the Metro Toronto Convention Centre in Toronto, Canada.

20 Apr 2010

Exercise machine for lumbago

Low back pain (or lumbago) is a common ailment often triggered by something as simple as lifting a suitcase. What is the best way to remedy the situation? An exercise machine designed specifically for back muscles could be the solution according to a new study published in the Journal of the American College of Sports Medicine.

20 Apr 2010

LSF gene plays important role in development and progression of HCC: VCU researchers

Virginia Commonwealth University researchers have identified a new tumor-promoting gene that may play a key role in the development of liver cancer. Levels of the gene's expression are significantly higher in more than 90 percent of patients with the disease compared to their healthy counterparts.

20 Apr 2010

EpiCept announces U.K. launch of Ceplene

EpiCept Corporation today announced that the commercial launch of Ceplene® (histamine dihydrochloride) will take place in the United Kingdom on April 20, 2010 in conjunction with the British Society for Haematology 50th Annual Scientific Meeting in Edinburgh, Scotland. Ceplene is approved in the European Union for the remission maintenance and prevention of relapse in patients with Acute Myeloid Leukemia (AML) in first remission.

20 Apr 2010

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced updated overall survival findings from a phase I/II study of nab®-paclitaxel (ABRAXANE® for Injectable Suspension) (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) given in combination with gemcitabine, demonstrated increased survival of the first-line treatment of patients with advanced pancreatic cancer.

19 Apr 2010

ConvaTec's Vitala Continence Control Device receives 2010 Medical Design Excellence Award

ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today that the Vitala™ Continence Control Device (CCD) has received a 2010 Medical Design Excellence Award.

19 Apr 2010

Biomarkers to help predict development of aggressive colorectal cancer discovered

Researchers at the University of Alabama at Birmingham (UAB) Department of Pathology have discovered a set of four biomarkers that will help predict which patients are more likely to develop aggressive colorectal cancer and which are not. The findings also shed light on the genetics that result in worse colorectal cancer-treatment outcomes for African-Americans, compared with Caucasians, the researchers said.

19 Apr 2010

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Medical experts from across the UK are gathering at the University of Leicester on Friday 23rd April in a Valedictory Symposium to celebrate the work of Professor David Taylor.

19 Apr 2010

Potential drug to annul ADAM-17 protein activity needed

Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis - the process of forming new neurons from mother cells - in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death.

19 Apr 2010

End-of-life care documentation helps in emergency treatment decisions

When Heather Rubesch was a teenager, her aunt died in need of a kidney transplant. In later family discussions, Heather's mother, Linda, expressed some of her views about end-of-life care—for instance, her belief in organ donation.

19 Apr 2010

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Individuals involved in rescue, recovery, demolition, and clean-up after the World Trade Center (WTC) disaster on September 11, 2001, were exposed to a complex mixture of airborne smoke, dust, combustion gases, acid mists, and metal fumes. The impact of this exposure on responders' upper and lower respiratory function has been well documented, but little is known about its impact on their sensitivity to odor and irritants.

19 Apr 2010

Stanford researchers discover tissue-specific target in pathogen

A tumor-causing maize fungus with the unsavory-sounding name "corn smut" wields different weapons from its genetic arsenal depending on which part of the plant it infects. The discovery by Stanford researchers marks the first time tissue-specific targeting has been found in a pathogen.

19 Apr 2010

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

At the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.

19 Apr 2010

Vehicle safety improvements do not benefit all segments of population: Study

Improvements in motor vehicle safety have been recognized by the Centers for Disease Control and Prevention as ranking among the 20th century's top public health achievements, however a recent study led by researchers in the Department of Preventive Medicine and Biometrics at the Uniformed Services University of the Health Sciences seems to show that the improvements aren't benefiting all segments of the population equally.

19 Apr 2010

Medicine News and Research

Mount Sinai School of Medicine ranked 18th among America's medical schools

ThromboGenics microplasmin Phase III program for symptomatic focal VMA meets primary endpoint

Thousands of premature babies could benefit from probiotics

UAB researchers discover four miRNAs to assess survival rate of colorectal cancer patients

Homeopathy – Is it a safer and effective alternative?

Viral Genetics relocates research facilities to Georgetown

Atherotech to showcase VAP Cholesterol Test at Internal Medicine 2010

Exercise machine for lumbago

LSF gene plays important role in development and progression of HCC: VCU researchers

EpiCept announces U.K. launch of Ceplene

Updated survival data from Phase I/II trial of nab-paclitaxel, gemcitabine combination for pancreatic cancer

ConvaTec's Vitala Continence Control Device receives 2010 Medical Design Excellence Award

Biomarkers to help predict development of aggressive colorectal cancer discovered

Valedictory Symposium to celebrate Professor David Taylor's contribution to Obstetrics and Gynaecology

Potential drug to annul ADAM-17 protein activity needed

End-of-life care documentation helps in emergency treatment decisions

Exposure to dust after WTC collapse impairs ability to detect odors and sense irritants

Stanford researchers discover tissue-specific target in pathogen

Radiolabeled hedgehog can differentiate stem-like cancer cells, identify aggressive tumors

Vehicle safety improvements do not benefit all segments of population: Study

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News